Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review
June 2019
44
About the Report
About the Report
Celltrion Inc (068270)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer and seasonal influenza. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.
Celltrion Inc Key Recent Developments
Oct 23,2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology
Oct 04,2018: Celltrion to Complete Expansion in Incheon, South Korea Facility
Sep 25,2018: FDA Issues Form 483 to Celltrion Inc
Sep 18,2018: Celltrion receives EIR from the FDA
Jun 26,2018: Celltrion to Launch Bio CDMO in Incheon, South Korea
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Celltrion Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
ViroMed Co Ltd
Peptron Inc
JW Pharmaceutical Corp
Genexine Inc
ChoongAng Vaccine Laboratory
Biosolution Co Ltd
Alvogen Korea Co Ltd
Advanced Protein Technologies Corp
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Celltrion Inc-Key Facts
Celltrion Inc-Key Employees
Celltrion Inc-Key Employee Biographies
Celltrion Inc-Major Products and Services
Celltrion Inc-History
Celltrion Inc-Company Statement
Celltrion Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Celltrion Inc-Business Description
Business Segment: Biopharmaceuticals
Overview
Performance
Business Segment: Chemical Medicines
Overview
Performance
Business Segment: Other
Overview
Performance
R&D Overview
Celltrion Inc-SWOT Analysis
SWOT Analysis-Overview
Celltrion Inc-Strengths
Celltrion Inc-Weaknesses
Celltrion Inc-Opportunities
Celltrion Inc-Threats
Celltrion Inc-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Celltrion Inc, Recent Deals Summary
Section 5-Company's Recent Developments
Oct 23, 2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology
Oct 04, 2018: Celltrion to Complete Expansion in Incheon, South Korea Facility
Sep 25, 2018: FDA Issues Form 483 to Celltrion Inc
Sep 18, 2018: Celltrion receives EIR from the FDA
Jun 26, 2018: Celltrion to Launch Bio CDMO in Incheon, South Korea
Jun 05, 2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs
May 16, 2018: FDA Issues Complete Response Letters to Celltrion for Two Biosimlars
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Celltrion Inc, Performance Chart (2014-2018)
Celltrion Inc, Ratio Charts
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Celltrion Inc, Key Facts
Celltrion Inc, Key Employees
Celltrion Inc, Key Employee Biographies
Celltrion Inc, Major Products and Services
Celltrion Inc, History
Celltrion Inc, Subsidiaries
Celltrion Inc, Key Competitors
Celltrion Inc, Ratios based on current share price
Celltrion Inc, Annual Ratios
Celltrion Inc, Annual Ratios (Cont...1)
Celltrion Inc, Annual Ratios (Cont...2)
Celltrion Inc, Interim Ratios
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Celltrion Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.